For years, people considering GLP-1 treatment for weight management have largely associated semaglutide with injections. That changed in 2026.

Oral semaglutide is now authorised in the UK for weight management, giving eligible adults another way to receive semaglutide without a weekly injection. For more information book your consultation with a doctor.

But does a tablet work in the same way as an injection? Is oral semaglutide better for some people? And what about microdosing or using a lower dose?

The answer is more nuanced than simply choosing between a tablet and an injection.

The most appropriate treatment depends on the individual, including medical history, treatment goals, tolerability, lifestyle, preferences and response to treatment.

What is oral wegovy?

Semaglutide is a GLP-1 receptor agonist that acts on pathways involved in appetite regulation and food intake.

The new oral semaglutide formulation is taken as a tablet once daily and is authorised in the UK for weight management in eligible adults with obesity, or adults who are overweight with at least one weight-related health condition.

Unlike injectable semaglutide, the tablet has specific administration requirements.

It should be taken once daily on an empty stomach after an overnight fasting period, with a small amount of water. The patient should then wait at least 30 minutes before eating, drinking or taking other oral medicines.

This is important because absorption of oral semaglutide is affected by how the tablet is taken.

How does wegovy tablets compare with injectable semaglutide?

Both contain the same active ingredient—semaglutide—but they are administered differently.

Oral Wegovy

Oral semaglutide is:

• Taken once daily
• Taken as a tablet
• Taken on an empty stomach
• Subject to specific timing requirements around food and other medicines
• Gradually increased over several months

The authorised oral dosing schedule starts at a low dose and progresses through several dose levels before reaching the maintenance dose.

Injectable semaglutide

Injectable semaglutide is:

• Administered once weekly
• Given as a subcutaneous injection
• Taken at any time of day, with or without food
• Gradually increased over time
• Available in different strengths depending on the treatment stage and indication

For weight management, the standard escalation begins at 0.25 mg once weekly and increases gradually.

The slower escalation is designed to improve tolerability, particularly gastrointestinal tolerability.

Which is more effective: tablet or injection?

It is tempting to assume that one route must automatically be better than the other.

However, the comparison is not that simple.

Clinical evidence supports semaglutide as an effective treatment for weight management, but oral and injectable formulations use different dosing schedules and have different pharmacokinetic characteristics.

The current UK product information specifically notes that oral semaglutide has greater variability in absorption than injectable semaglutide.

Therefore, treatment should not be viewed simply as:

tablet = weaker

or

injection = stronger.

The more useful question is:

Which treatment is appropriate and sustainable for this individual patient?

What about side effects?

Both oral and injectable semaglutide can cause gastrointestinal side effects.

These may include:

• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Abdominal discomfort
• Indigestion or reflux-type symptoms

Side effects are particularly common during dose escalation.

This is one reason why gradual dose increases are an important part of treatment.

If a patient develops significant gastrointestinal symptoms, the appropriate response may be to delay further escalation or consider returning to a previously tolerated dose, depending on the clinical circumstances.

Treatment should therefore be monitored rather than viewed as a simple race towards the highest dose.

Does oral semaglutide mean no injections?

Yes.

For someone who strongly dislikes needles, the availability of an oral semaglutide formulation may make semaglutide treatment more acceptable.

However, a tablet introduces its own routine.

It needs to be taken correctly every day, on an empty stomach, with specific timing before food, drinks and other oral medicines.

For some people, that daily routine may be straightforward.

For others, a once-weekly injection may fit more easily into everyday life.

There is therefore no universal answer.

What is GLP-1 microdosing?

The term “microdosing” is increasingly used by patients to describe using a lower dose of a GLP-1 medicine or taking a slower approach to dose escalation.

However, it is important to distinguish this from the licensed dosing schedules.

There is currently no separate licensed indication called “GLP-1 microdosing”.

Instead, clinicians may individualise treatment within the authorised prescribing framework according to the patient's response, tolerability and clinical circumstances.

For example, if a patient is experiencing significant gastrointestinal symptoms during escalation, the product information allows clinicians to consider delaying escalation or returning to a previously tolerated dose until symptoms improve.

The principle is therefore not:

“The lowest dose is always best.”

It is:

“Use an appropriate treatment strategy and only increase treatment when clinically appropriate.”

Can oral semaglutide be microdosed?

This requires particular care.

The authorised oral semaglutide regimen uses specific tablet strengths and dose-escalation steps. The tablets should not be split, crushed or chewed, and the prescribing information states that patients should not take more than one tablet per day to achieve a higher dose.

Consequently, taking fractions of tablets or creating an improvised dosing schedule should not be confused with an evidence-based microdosing programme.

A doctor-led approach should remain within the authorised product information unless there is a specific clinical reason to consider otherwise.

Can you switch between oral and injectable semaglutide?

Switching is possible in appropriate circumstances, but it should be medically supervised.

The current UK product information provides specific guidance for switching between formulations.

Importantly, it also states that the effect of switching cannot be predicted easily because absorption of oral semaglutide is more variable than injectable semaglutide.

This means that patients should not simply calculate an equivalent dose themselves.

A clinician should review the treatment history, current dose, response, tolerability and other medicines before making a change.

Oral semaglutide vs injections: which should you choose?

There is no single treatment that is right for everybody.

A tablet may appeal to someone who strongly prefers to avoid injections.

A weekly injection may suit someone who prefers not to take a daily tablet with specific fasting and timing requirements.

Other factors can be even more important, including:

• Your medical history
• Your current medicines
• Your weight and health goals
• Appetite and cravings
• Previous experience with weight-management treatment
• Gastrointestinal tolerability
• Your response to treatment
• Your ability to follow the dosing instructions
• Your preferences and lifestyle

This is why medical weight management should be personalised.

The 121 Clinic approach

At 121 Clinic, we believe that weight management should be doctor-led, personalised and clinically monitored.

We don't believe that successful treatment simply means reaching the highest possible dose.

Instead, we look at the whole patient.

That includes your appetite, weight trajectory, cravings, food noise, nutrition, lifestyle, medical history, medication response and tolerability.

Where appropriate, treatment can be introduced gradually and reviewed carefully.

The objective is not simply to prescribe medication.

It is to develop a treatment strategy that is medically appropriate, effective and sustainable for the individual.

Oral semaglutide or injectable treatment: the bottom line

The introduction of oral semaglutide gives eligible patients another option for weight management.

For some people, avoiding injections may be an important consideration.

For others, the convenience of once-weekly administration may make an injectable treatment more suitable.

Neither option should automatically be considered “better”.

The right choice depends on the individual patient.

And when it comes to microdosing, it is important to separate genuine clinical individualisation and careful dose escalation from unlicensed or improvised dosing strategies.

The goal isn't the highest dose.

The goal is the right treatment strategy for the right patient, under appropriate medical supervision.

If you are considering medical weight management and want to understand the options available to you, a doctor-led consultation can help you make an informed decision based on your individual circumstances.

Book your consultation today!

At 121 Clinic, we provide doctor-led GLP-1 weight loss treatment for patients in Bedford, Windsor, Teddington, Richmond, Manchester, Beaconsfield, London, Kent, Liverpool, Sheffield, Leeds, Newcastle, Buckinghamshire,  and surrounding areas.